AMPER study for mild to moderate Alzheimer's
Part of Brain & nervous system, Mental health clinical trials.
This study tests if a new approach (AMPER) can help people with mild to moderate Alzheimer's disease. It looks at how your thinking and daily function change over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with probable Alzheimer's disease that is mild to moderate in severity.
- You are 50 years old or older.
- You have adequate vision, hearing, and speech (with glasses or hearing aids if needed) to complete the study tasks.
- You have a family member or caregiver who can attend all visits and help with the study.
- You have an Addenbrooke's Cognitive Examination (ACE III) score between 20 and 82, or an equivalent score on another thinking test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) perform on standardized memory/brain tests. It may help researchers understand changes over time, and whether certain types of brain signals or test results track with the condition.
This study tests whether a digital support program can help people with early memory problems and their families. It takes place in Barcelona and involves using apps or tablets during regular visits.
This trial tests whether a gentle, non-invasive brain stimulation (transcranial alternating current) can improve memory and thinking in people with early Alzheimer's or mild memory problems. It involves regular sessions of stimulation and check-ups over several months.
This trial tests a personalized brain stimulation treatment for older adults with mild memory or thinking problems caused by Alzheimer's disease. It aims to see if tailored stimulation can improve cognitive function.
This study tests whether a special type of brain stimulation called 40Hz BCI (brain-computer interface) might help slow memory loss in people with Alzheimer's disease. You would receive daily stimulation sessions at home with help from a caregiver.
This trial tests an investigational drug called Neuroaid II (MLC901) for people with mild to moderate Alzheimer's disease. It aims to see if the drug can help slow down memory and thinking problems.
Hear when a new Alzheimer's Dementia (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.